Phase Ii study of Baker's antifol in advanced colorectal cancer
Padilla, F.; Correa, J.; Buroker, T.; Vaitkevicius, V.K.
Cancer Treatment Reports 62(4): 553-554
1978
ISSN/ISBN: 0361-5960 PMID: 350391 Document Number: 136038
Document emailed within 1 workday
Related Documents
Lawton, J.O.; Giles, G.R.; Hall, J.; MacAdam, A.; Hall, R.; Matheson, T.; Bird, G. 1981: Phase Ii study of chlorozotocin in the treatment of advanced colorectal cancer Cancer Treatment Reports 65(1-2): 13-15Becouarn, Y.; Rougier, P. 1998: Clinical efficacy of oxaliplatin monotherapy: phase Ii trials in advanced colorectal cancer Seminars in Oncology 25(2 Suppl 5: 23-31
Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669
Vogel, S.J.; Presant, C.A.; Ratkin, G.A.; Klahr, C. 1979: Phase i study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma Cancer Treatment Reports 63(1): 1-5
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Toyokawa, A.; Tsujimura, T.; Hamabe, Y.; Sato, S.; Mukubou, H.; Wakahara, T.; Kaji, M.; Tsukamoto, T.; Wakita, K.; Onishi, N.; Ishida, T.; Watanabe, A.; Fujiwara, H.; Mukai, H. 2005: Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(13): 2087-2090
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650
Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S. 1986: Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 70(9): 1125-1126
Rouësse, J.G.; Le Chevalier, T.; Caille, P.; Mondesir, J.M.; Sancho-Garnier, H.; May-Levin, F.; Spielmann, M.; De Jager, R.; Amiel, J.L. 1985: Phase Ii study of elliptinium in advanced breast cancer Cancer Treatment Reports 69(6): 707-708
Yap, H.Y.; Salem, P.; Hortobagyi, G.N.; Bodey, G.P.; Buzdar, A.U.; Tashima, C.K.; Blumenschein, G.R. 1978: Phase Ii study of cis-dichlorodiammineplatinum(II) in advanced breast cancer Cancer Treatment Reports 62(3): 405-408
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Lionetto, R.; Pronzato, P.; Conte, P.F.; Sertoli, M.R.; Amoroso, D.; Rosso, R. 1986: Idarubicin in advanced breast cancer: a phase II study Cancer Treatment Reports 70(12): 1439-1440
Ettinger, D.S.; Orr, D.W.; Rice, A.P.; Donehower, R.C. 1985: Phase i study of N-methylformamide in patients with advanced cancer Cancer Treatment Reports 69(5): 489-493
Edmonson, J.H.; Rubin, J.; Kvols, L.K.; O'Connell, M.J.; Frytak, S.; Green, S.J. 1981: Phase II study of maytansine in advanced breast cancer Cancer Treatment Reports 65(5-6): 536-537
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Thongprasert, S.; Maoleekoonpairoj, S.; Laohavinij, S.; Thavichaigarn, P. 2000: Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study Journal of the Medical Association of Thailand 83(6): 676-680
Kurtz, J.E.; Kohser, F.; Négrier, S.; Trillet-Lenoir, V.; Walter, S.; Limacher, J.M.; Untereiner, M.; Kayitalire, L.; Jaeck, D.; Dufour, P. 2000: Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study Hepato-Gastroenterology 47(35): 1450-1453
Amadori, D.; Frassineti, G.L.; Zoli, W.; Tienghi, A.; Ravaioli, A.; Casadei Giunchi, D.; Gentile, A.; Salzano, E. 1996: A Phase I/Ii study of paclitaxel and doxorubicin in the treatment of advanced breast cancer Seminars in Oncology 23(1 Suppl 1: 19-23
Inuyama, Y.; Kida, A.; Tsukuda, M.; Kohno, N.; Satake, B. 2001: Late phase Ii study of S-1 in patients with advanced head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(10): 1381-1390
Kurtz, J-Emmanuel.; Négrier, S.; Husseini, F.; Limacher, J-Marc.; Borel, C.; Wagner, J-Philippe.; Prévot, G.; Bergerat, J-Pierre.; Dufour, P. 2003: A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer Hepato-Gastroenterology 50(50): 567-570